105,000 Shares in AdaptHealth Corp. (NASDAQ:AHCO) Acquired by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. bought a new position in shares of AdaptHealth Corp. (NASDAQ:AHCO) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 105,000 shares of the company’s stock, valued at approximately $1,000,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Blue Trust Inc. increased its position in AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock worth $55,000 after purchasing an additional 1,115 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its position in AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after acquiring an additional 1,690 shares in the last quarter. Rhumbline Advisers grew its position in AdaptHealth by 0.5% in the fourth quarter. Rhumbline Advisers now owns 313,110 shares of the company’s stock valued at $2,981,000 after acquiring an additional 1,691 shares in the last quarter. Mutual of America Capital Management LLC grew its position in AdaptHealth by 23.8% in the third quarter. Mutual of America Capital Management LLC now owns 15,893 shares of the company’s stock valued at $178,000 after acquiring an additional 3,052 shares in the last quarter. Finally, LRI Investments LLC grew its position in AdaptHealth by 32.0% in the third quarter. LRI Investments LLC now owns 15,331 shares of the company’s stock valued at $172,000 after acquiring an additional 3,713 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on AHCO shares. Truist Financial lowered their price objective on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, November 15th. Royal Bank of Canada lowered their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research report on Tuesday, November 19th. Robert W. Baird lowered their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday, November 6th. Canaccord Genuity Group reduced their target price on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Finally, UBS Group reduced their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $12.20.

AdaptHealth Stock Performance

Shares of AHCO opened at $8.77 on Friday. The business’s fifty day moving average price is $9.88 and its 200 day moving average price is $10.20. AdaptHealth Corp. has a 12-month low of $7.01 and a 12-month high of $11.90. The stock has a market capitalization of $1.18 billion, a PE ratio of -5.32, a price-to-earnings-growth ratio of 1.11 and a beta of 1.12. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.